Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernia, Ventral | 9 | 2018 | 17 | 1.840 |
Why?
|
| Surgical Mesh | 11 | 2014 | 22 | 1.670 |
Why?
|
| Herniorrhaphy | 9 | 2018 | 27 | 1.580 |
Why?
|
| Hernia, Inguinal | 7 | 2016 | 16 | 1.280 |
Why?
|
| Postoperative Complications | 20 | 2018 | 957 | 1.250 |
Why?
|
| Obesity, Morbid | 2 | 2017 | 73 | 1.100 |
Why?
|
| Laparoscopy | 13 | 2016 | 145 | 1.040 |
Why?
|
| Adenocarcinoma | 6 | 2016 | 189 | 1.000 |
Why?
|
| Esophageal Neoplasms | 7 | 2002 | 45 | 0.930 |
Why?
|
| Stomach Neoplasms | 3 | 2016 | 30 | 0.760 |
Why?
|
| General Surgery | 4 | 2015 | 49 | 0.660 |
Why?
|
| Cholecystectomy, Laparoscopic | 7 | 2015 | 35 | 0.590 |
Why?
|
| Middle Aged | 41 | 2018 | 9823 | 0.570 |
Why?
|
| Gastroplasty | 1 | 2016 | 21 | 0.570 |
Why?
|
| Clinical Clerkship | 3 | 2013 | 22 | 0.550 |
Why?
|
| Gastric Bypass | 1 | 2016 | 52 | 0.540 |
Why?
|
| Aged | 30 | 2018 | 9448 | 0.530 |
Why?
|
| Carcinoma | 3 | 2016 | 57 | 0.520 |
Why?
|
| Male | 44 | 2020 | 15621 | 0.520 |
Why?
|
| Treatment Outcome | 21 | 2018 | 3478 | 0.490 |
Why?
|
| Educational Measurement | 3 | 2015 | 59 | 0.470 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2003 | 20 | 0.470 |
Why?
|
| Humans | 59 | 2020 | 29337 | 0.470 |
Why?
|
| Recurrence | 10 | 2017 | 350 | 0.460 |
Why?
|
| Adult | 29 | 2018 | 8601 | 0.450 |
Why?
|
| Quality Improvement | 4 | 2014 | 158 | 0.440 |
Why?
|
| Female | 41 | 2018 | 16197 | 0.430 |
Why?
|
| Colonic Neoplasms | 3 | 2016 | 66 | 0.430 |
Why?
|
| Hepatectomy | 6 | 2015 | 55 | 0.430 |
Why?
|
| Retrospective Studies | 24 | 2018 | 3273 | 0.430 |
Why?
|
| Esophagectomy | 5 | 2002 | 21 | 0.410 |
Why?
|
| Liver Neoplasms | 5 | 2000 | 103 | 0.410 |
Why?
|
| Colectomy | 3 | 2016 | 19 | 0.400 |
Why?
|
| Curriculum | 2 | 2003 | 155 | 0.390 |
Why?
|
| Polytetrafluoroethylene | 2 | 2003 | 5 | 0.390 |
Why?
|
| Pancreatic Neoplasms | 4 | 2013 | 142 | 0.340 |
Why?
|
| Students, Medical | 2 | 2013 | 46 | 0.310 |
Why?
|
| Aged, 80 and over | 12 | 2017 | 4851 | 0.300 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2007 | 74 | 0.290 |
Why?
|
| Risk Factors | 9 | 2018 | 2443 | 0.290 |
Why?
|
| Survival Rate | 9 | 2015 | 349 | 0.280 |
Why?
|
| Prospective Studies | 9 | 2014 | 1811 | 0.270 |
Why?
|
| Smoking | 2 | 2016 | 194 | 0.260 |
Why?
|
| Hernia, Hiatal | 2 | 2014 | 11 | 0.250 |
Why?
|
| Polypropylenes | 1 | 2003 | 2 | 0.230 |
Why?
|
| Gastrectomy | 3 | 2015 | 24 | 0.230 |
Why?
|
| Prognosis | 6 | 2017 | 840 | 0.220 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 1830 | 0.220 |
Why?
|
| Colorectal Neoplasms | 4 | 1997 | 82 | 0.220 |
Why?
|
| Cholangiography | 4 | 2015 | 11 | 0.220 |
Why?
|
| Ultrasonography | 4 | 2020 | 226 | 0.210 |
Why?
|
| Laparotomy | 3 | 2020 | 21 | 0.210 |
Why?
|
| Hernia, Femoral | 1 | 2001 | 1 | 0.200 |
Why?
|
| Mesenteric Cyst | 1 | 2020 | 1 | 0.190 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 6 | 0.190 |
Why?
|
| Lymphokines | 1 | 2000 | 9 | 0.190 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 6 | 0.190 |
Why?
|
| United States | 9 | 2016 | 2333 | 0.190 |
Why?
|
| Early Diagnosis | 1 | 2020 | 65 | 0.190 |
Why?
|
| Elective Surgical Procedures | 2 | 2017 | 43 | 0.190 |
Why?
|
| Peritoneum | 2 | 2003 | 18 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 1 | 2000 | 56 | 0.180 |
Why?
|
| Adolescent | 6 | 2007 | 2279 | 0.180 |
Why?
|
| Pneumonia | 2 | 2016 | 67 | 0.170 |
Why?
|
| Suture Techniques | 3 | 2007 | 141 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 1997 | 178 | 0.170 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2018 | 3 | 0.170 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 175 | 0.170 |
Why?
|
| Conservative Treatment | 1 | 2018 | 13 | 0.170 |
Why?
|
| Cholelithiasis | 1 | 1998 | 10 | 0.170 |
Why?
|
| Compartment Syndromes | 1 | 2018 | 11 | 0.170 |
Why?
|
| Gallstones | 1 | 1998 | 6 | 0.170 |
Why?
|
| Cholecystectomy | 3 | 2013 | 16 | 0.170 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 97 | 0.160 |
Why?
|
| Pancreaticoduodenectomy | 2 | 2013 | 27 | 0.160 |
Why?
|
| Lipoma | 1 | 2017 | 7 | 0.160 |
Why?
|
| Myoepithelioma | 1 | 2017 | 2 | 0.160 |
Why?
|
| Liver | 2 | 1997 | 173 | 0.150 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2017 | 24 | 0.150 |
Why?
|
| Trachea | 1 | 1997 | 31 | 0.150 |
Why?
|
| Internship and Residency | 3 | 2015 | 211 | 0.150 |
Why?
|
| Databases, Factual | 5 | 2016 | 330 | 0.150 |
Why?
|
| Analysis of Variance | 3 | 2003 | 321 | 0.150 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1996 | 4 | 0.150 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 6 | 0.140 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.140 |
Why?
|
| Survival Analysis | 5 | 2015 | 298 | 0.140 |
Why?
|
| Portal Vein | 1 | 1996 | 40 | 0.140 |
Why?
|
| Prostheses and Implants | 1 | 1997 | 166 | 0.140 |
Why?
|
| Thrombosis | 1 | 1996 | 59 | 0.140 |
Why?
|
| Radiation Tolerance | 1 | 1995 | 7 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 46 | 0.140 |
Why?
|
| Fundoplication | 2 | 2013 | 20 | 0.140 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2015 | 7 | 0.130 |
Why?
|
| Neoplasm Staging | 5 | 2015 | 340 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2015 | 28 | 0.130 |
Why?
|
| Organs at Risk | 1 | 2015 | 15 | 0.130 |
Why?
|
| Certification | 1 | 2015 | 49 | 0.130 |
Why?
|
| Liver Regeneration | 1 | 1995 | 24 | 0.130 |
Why?
|
| Radiation Oncology | 1 | 2015 | 17 | 0.130 |
Why?
|
| Gallbladder Neoplasms | 1 | 2015 | 6 | 0.130 |
Why?
|
| Hospital Costs | 1 | 1996 | 68 | 0.130 |
Why?
|
| Esophagus | 2 | 2012 | 59 | 0.130 |
Why?
|
| Body Mass Index | 1 | 2017 | 428 | 0.130 |
Why?
|
| Clinical Competence | 3 | 2013 | 230 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 9 | 0.130 |
Why?
|
| Appendectomy | 1 | 2014 | 15 | 0.130 |
Why?
|
| Logistic Models | 4 | 2016 | 407 | 0.130 |
Why?
|
| Safety | 2 | 2007 | 45 | 0.130 |
Why?
|
| Appendicitis | 1 | 2014 | 18 | 0.130 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 67 | 0.130 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 26 | 0.130 |
Why?
|
| Lymphoma | 1 | 2014 | 44 | 0.130 |
Why?
|
| Sarcoma | 1 | 2015 | 65 | 0.130 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 324 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 132 | 0.120 |
Why?
|
| Biliary Dyskinesia | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cholestasis | 1 | 1993 | 8 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2014 | 33 | 0.120 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 3 | 0.120 |
Why?
|
| Pain, Postoperative | 3 | 2013 | 314 | 0.120 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 31 | 0.120 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 5 | 0.120 |
Why?
|
| Duodenal Neoplasms | 1 | 2013 | 7 | 0.120 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 30 | 0.120 |
Why?
|
| Length of Stay | 5 | 2014 | 317 | 0.120 |
Why?
|
| Stents | 1 | 1993 | 76 | 0.120 |
Why?
|
| Abdominal Wall | 1 | 2013 | 4 | 0.110 |
Why?
|
| Operative Time | 4 | 2014 | 80 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 31 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1113 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 333 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 79 | 0.110 |
Why?
|
| Sepsis | 1 | 2014 | 144 | 0.110 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 295 | 0.110 |
Why?
|
| Prosthesis Implantation | 2 | 2013 | 33 | 0.110 |
Why?
|
| Kidney | 1 | 2013 | 173 | 0.110 |
Why?
|
| Esophageal Achalasia | 1 | 2012 | 19 | 0.110 |
Why?
|
| Morbidity | 3 | 2014 | 63 | 0.100 |
Why?
|
| Lymph Node Excision | 2 | 2015 | 26 | 0.090 |
Why?
|
| Time Factors | 3 | 2014 | 1616 | 0.090 |
Why?
|
| Program Evaluation | 2 | 2013 | 132 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 389 | 0.080 |
Why?
|
| Hernia, Abdominal | 1 | 2007 | 2 | 0.080 |
Why?
|
| Polyurethanes | 1 | 2007 | 9 | 0.080 |
Why?
|
| Omentum | 1 | 2007 | 8 | 0.080 |
Why?
|
| Chicago | 2 | 2001 | 865 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2000 | 138 | 0.080 |
Why?
|
| Reoperation | 4 | 2016 | 932 | 0.070 |
Why?
|
| Child | 3 | 2001 | 1346 | 0.070 |
Why?
|
| Age Factors | 2 | 2016 | 843 | 0.070 |
Why?
|
| Sutures | 2 | 2003 | 41 | 0.070 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 34 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 553 | 0.060 |
Why?
|
| Algorithms | 2 | 2015 | 400 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2015 | 770 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 1442 | 0.060 |
Why?
|
| Comorbidity | 2 | 2016 | 498 | 0.060 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 300 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 175 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 96 | 0.050 |
Why?
|
| Probability | 1 | 2002 | 94 | 0.050 |
Why?
|
| Workload | 1 | 2001 | 33 | 0.050 |
Why?
|
| Models, Educational | 1 | 2001 | 36 | 0.050 |
Why?
|
| Bile | 1 | 2020 | 5 | 0.050 |
Why?
|
| Intraoperative Care | 2 | 1998 | 44 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 9 | 0.050 |
Why?
|
| von Willebrand Factor | 1 | 2000 | 12 | 0.050 |
Why?
|
| Barrett Esophagus | 1 | 2000 | 11 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2017 | 679 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 1184 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2000 | 65 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2000 | 81 | 0.050 |
Why?
|
| Infant | 1 | 2001 | 531 | 0.040 |
Why?
|
| Endosonography | 1 | 1999 | 11 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 642 | 0.040 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 1999 | 3 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 184 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 9 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 1998 | 24 | 0.040 |
Why?
|
| Patient Selection | 1 | 2000 | 232 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 604 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1997 | 364 | 0.040 |
Why?
|
| Bronchial Neoplasms | 1 | 1997 | 5 | 0.040 |
Why?
|
| Groin | 1 | 2017 | 4 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 1997 | 68 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2017 | 16 | 0.040 |
Why?
|
| Pilot Projects | 2 | 1997 | 394 | 0.040 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 21 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 62 | 0.040 |
Why?
|
| Thigh | 1 | 2017 | 34 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 101 | 0.040 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 4 | 0.040 |
Why?
|
| Intestinal Polyps | 1 | 1996 | 1 | 0.040 |
Why?
|
| Sigmoid Neoplasms | 1 | 1996 | 1 | 0.040 |
Why?
|
| Cryosurgery | 1 | 1997 | 20 | 0.040 |
Why?
|
| Mesenteric Veins | 1 | 1996 | 2 | 0.040 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2016 | 9 | 0.040 |
Why?
|
| Angina Pectoris | 1 | 2016 | 17 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 521 | 0.040 |
Why?
|
| Rectal Neoplasms | 1 | 1996 | 19 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 391 | 0.040 |
Why?
|
| Cost Savings | 1 | 1996 | 36 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 42 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 1 | 0.030 |
Why?
|
| Bilirubin | 1 | 1995 | 6 | 0.030 |
Why?
|
| Cardia | 1 | 1995 | 3 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 1995 | 18 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1995 | 21 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 144 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 107 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 101 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 146 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 138 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 118 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 63 | 0.030 |
Why?
|
| Consensus | 1 | 2015 | 105 | 0.030 |
Why?
|
| Jejunum | 1 | 1994 | 10 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 1994 | 6 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 496 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1994 | 39 | 0.030 |
Why?
|
| Radiography | 1 | 1996 | 678 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 148 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 451 | 0.030 |
Why?
|
| Hypertension | 1 | 2016 | 266 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 141 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 241 | 0.030 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 5 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 64 | 0.030 |
Why?
|
| Ileus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 168 | 0.030 |
Why?
|
| Seroma | 1 | 2013 | 5 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2013 | 16 | 0.030 |
Why?
|
| Rats | 1 | 1995 | 854 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 1999 | 487 | 0.030 |
Why?
|
| Device Removal | 1 | 2013 | 85 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 724 | 0.030 |
Why?
|
| Intraoperative Period | 3 | 1997 | 29 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2013 | 638 | 0.030 |
Why?
|
| Spinal Fusion | 1 | 1999 | 516 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 1939 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 662 | 0.020 |
Why?
|
| Ischemia | 1 | 2007 | 27 | 0.020 |
Why?
|
| Surgical Instruments | 1 | 2007 | 25 | 0.020 |
Why?
|
| Blood Loss, Surgical | 2 | 1999 | 64 | 0.020 |
Why?
|
| Animals | 1 | 1995 | 4552 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 502 | 0.020 |
Why?
|
| Cystadenocarcinoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cystadenoma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1999 | 12 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1999 | 24 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1997 | 75 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1997 | 113 | 0.010 |
Why?
|
| Cisplatin | 1 | 1997 | 91 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1997 | 227 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1997 | 290 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1994 | 7 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 12 | 0.010 |
Why?
|
| Puerto Rico | 1 | 1993 | 12 | 0.010 |
Why?
|
| Bile Ducts | 1 | 1993 | 12 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 107 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1993 | 68 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1997 | 1221 | 0.010 |
Why?
|